Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 27,621 | 31,377 | 27,691 | 20,521 | 14,607 |
| Operating Income | -27,621 | -31,377 | -27,691 | -20,521 | -14,607 |
| Other Income | 2,117 | 1,283 | 731 | -85 | -3,221 |
| Pre-tax Income | -25,504 | -30,094 | -26,960 | -20,606 | -17,828 |
| Net Income Continuous | -25,504 | -30,094 | -26,960 | -20,606 | -17,828 |
| Net Income | $-25,504 | $-30,094 | $-26,960 | $-20,606 | $-17,828 |
| EPS Basic Total Ops | -0.20 | -0.24 | -0.21 | -0.18 | -1.97 |
| EPS Basic Continuous Ops | -0.20 | -0.24 | -0.21 | -0.18 | -1.58 |
| EPS Diluted Total Ops | -0.20 | -0.24 | -0.21 | -0.18 | -1.97 |
| EPS Diluted Continuous Ops | -0.20 | -0.24 | -0.21 | -0.18 | -1.58 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.24 | -0.21 | -0.18 | -1.97 |
| EBITDA(a) | $-27,604 | $-31,354 | $-27,683 | $-20,498 | $-14,560 |